
|Articles|May 24, 2019
ICON Acquires MeDiNova Research in Europe and Africa
Advertisement
ICON plc has announced that it has acquired a majority shareholding in MeDiNova Research, a site network with research sites in Europe and Africa, and that it has the right to acquire the remaining shares in the company by Quarter Three 2020. MeDiNova Research currently has a network of 33 active clinical research sites in the UK, Spain, South Africa, Poland and Romania.
For more information click
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Ziihera Combinations Show Significant Survival Benefits in Phase III HER2+ GEA Trial
2
ACT Brief: Digital Recruitment Strategies, Tremfya’s Long-Term PsA Results, and Agentic AI’s Enterprise Impact
3
Tailoring Recruitment Strategies Across Platforms and Patient Populations
4
Long-Term APEX Trial Data Reinforce Tremfya’s Sustained Psoriatic Arthritis Control and Structural Protection
5






.png)



.png)



.png)
.png)
